MyAverix Finance
F · Healthcare
Provexis plc (NZCA)
Drug Manufacturers - Specialty & Generic
Provexis plc (NZCA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $4.69M, P/E ratio is 18.00, net margin is -69.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NZCA
Provexis plc (NZCA) — FAQ
What is Provexis plc's market cap?
Provexis plc (NZCA) has a reported market cap of $4.69M (data as of 2026-03-30).
What is NZCA's P/E ratio?
The price-to-earnings (P/E) ratio for Provexis plc (NZCA) is 18.00 (data as of 2026-03-30).
Does Provexis plc pay a dividend?
Dividend yield is not available in the current snapshot for Provexis plc (NZCA). Check the MyAverix Finance app for the latest dividend data.
What sector is Provexis plc in?
Provexis plc (NZCA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is NZCA listed on?
NZCA is listed on F.
What is Provexis plc's net margin?
Provexis plc (NZCA) reports a net margin of -69.3% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.